{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "FRA", "shortName": "AELIS FARMA SAS EO -,004", "longName": "Aelis Farma SA", "messageBoardId": "finmb_260735442", "market": "dr_market", "marketState": "REGULAR", "trailingAnnualDividendRate": 0.0, "trailingPE": 43.281254, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": 0.32, "sharesOutstanding": 12501200, "bookValue": 1.913, "fiftyDayAverage": 14.0144, "fiftyDayAverageChange": -0.16439915, "fiftyDayAverageChangePercent": -0.0117307305, "twoHundredDayAverage": 11.85505, "tradeable": false, "cryptoTradeable": false, "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "esgPopulated": false, "regularMarketChangePercent": 0.7272755, "regularMarketPrice": 13.85, "regularMarketChange": 0.10000038, "regularMarketTime": 1683872225, "regularMarketDayHigh": 13.85, "regularMarketDayRange": "13.85 - 13.85", "regularMarketDayLow": 13.85, "regularMarketVolume": 180, "regularMarketPreviousClose": 13.75, "bid": 13.85, "ask": 14.0, "fullExchangeName": "Frankfurt", "financialCurrency": "EUR", "regularMarketOpen": 13.85, "averageDailyVolume3Month": 0, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 5.25, "fiftyTwoWeekLowChangePercent": 0.6104651, "fiftyTwoWeekRange": "8.6 - 14.2", "fiftyTwoWeekHighChange": -0.34999943, "fiftyTwoWeekHighChangePercent": -0.024647847, "fiftyTwoWeekLow": 8.6, "fiftyTwoWeekHigh": 14.2, "twoHundredDayAverageChange": 1.9949503, "twoHundredDayAverageChangePercent": 0.16827852, "marketCap": 174382592, "priceToBook": 7.2399373, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "prevName": "Aelis Farma S.A.S.", "nameChangeDate": "2023-05-11", "firstTradeDateMilliseconds": 1645426800000, "priceHint": 2, "symbol": "69O.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "146 rue L\u00e9o Saignat", "address2": "Neurocentre Magendie", "city": "Bordeaux", "zip": "33077", "country": "France", "phone": "33 5 57 57 37 70", "website": "https://www.aelisfarma.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Aelis Farma SA, a biotechnology company, engages in the research and development of treatments for brain diseases. It is developing signaling-specific inhibitors of the CB1 receptors, such as AEF0117, a drug candidate, which is in Phase 2b clinical trials for the treatment of the harmful effects of excessive cannabis use; and AEF0217, a drug candidate, which completed Phase 1 clinical trials to treat cognitive deficits observed in Down syndrome, as well as other cognitive impairments. The company was incorporated in 2013 and is based in Bordeaux, France.", "fullTimeEmployees": 20, "companyOfficers": [{"maxAge": 1, "name": "Dr. Pier Vincenzo Piazza M.D., Ph.D.", "age": 61, "title": "CEO & Director", "yearBorn": 1961, "fiscalYear": 2021, "totalPay": {"raw": 501137, "fmt": "501.14k", "longFmt": "501,137"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Marie Line Lefevre", "title": "Head of Fin.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Stephanie  Monlezun", "title": "Chief Operating Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Lea  Floquet", "title": "Head of Legal", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Sandy  Fabre", "title": "Head of Discovery & IP Leader", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Aurelie  Boucard", "title": "Head of Preclinical Devel.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Helle  Mengel", "title": "Head of Clinical Devel.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Corinne  Chaimbault", "title": "Head of Pharmaceutical Devel.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1640908800, "maxAge": 86400}}], "error": null}}